Osprey Medical says it raised a private placement worth about $11 million for its Avert device to prevent contrast-induced nephropathy.
Surgeons in San Francisco begin a 6-way kidney transplant chain involving 12 patients that began with a single altruistic donor.
(Reuters) — Doctors at a San Francisco hospital began an unusual series of kidney transplants yesterday with 6 living donors providing organs to 6 patients in a chain that began with a woman described as an altruistic donor unrelated to any of the recipients.
Medtronic is taking another shot at renal denervation to treat drug-resistant hypertension, a year after a pivotal trial for its key product in the space failed to meet its efficacy endpoint.
A massive Intuitive Surgical-backed study finds that using its da Vinci surgical robot to treat kidney cancer is improves outcomes and save costs over the long term.
Cardiac device-maker Medtronic and dialysis-provider DaVita Healthcare Partners plan to team up to identify and study cardiac arrhythmia in patients undergoing dialysis.
Home hemodialysis device maker NxStage Medical touts a new study showing that kidney patients who underwent frequent home hemodialysis had a better quality of life and lower risk of death than those who underwent peritoneal dialysis.
Astute Medical is in line to receive up to $30 million from funding partner CRG to commercialize its recently approved NephroCheck kidney-injury test.
Astute Medical said it's in line to receive up to $30 million under a standing loan agreement from funding partner CRG to commercialize its recently approved NephroCheck kidney-injury test, and could receive an additional $10 million if it hits certain revenue milestones.